Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy.
Ontology highlight
ABSTRACT: One of the central signaling pathways with a regulatory effect on cell proliferation and survival is Akt/mTOR. In many human cancer types, for instance, lung cancer, the overexpression of Akt/mTOR has been reported. For this reason, either targeting cancer cells by synthetic or natural products affecting the Akt/mTOR pathway down-regulation is a useful strategy in cancer therapy. Direct inhibition of the signaling pathway or modulation of each related molecule could have significant feedback on the growth and proliferation of cancer cells. A variety of secondary metabolites has been identified to directly inhibit the AKT/mTOR signaling, which is important in the field of drug discovery. Naturally occurring nitrogenous and phenolic compounds can emerge as two pivotal classes of natural prod
SUBMITTER: Ghareghomi S
PROVIDER: S-EPMC9871280 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA